Victor Weerts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Victor Weerts has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Adil Salihu
Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
2 shared publications - David Meier
Department of Cardiology, Lausanne University Hospital and University of Lausanne, 1015 Lausanne, Switzerland
2 shared publications - Olivier Muller
Cardiology Department, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland
2 shared publications - Quentin Liabot
Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
2 shared publications - Stephane Fournier
Department of Cardiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
2 shared publications - Aurelia Zimmerli
Cardiology Department, Lausanne University Hospital and University of Lausanne, 1005 Lausanne, Switzerland
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e88399
Human vs Artificial Intelligence in Detecting Coronary Occlusions in ST-Elevation Myocardial Infarction: Retrospective Study
Background: Occlusion myocardial infarction (OMI) on the electrocardiogram (ECG) can present as ST-elevation myocardial infarction (STEMI), non-STEMI, ST depression, or other patterns (eg, de Winter T waves and hyperacute T waves), posing a diagnostic challenge. Even experienced physicians may overlook OMI on ECG, leading to delays in catheterization laboratory activation. Recently, smartphone apps using AI have been shown to exhibit promising accuracy in ECG interpretation in large datasets. Objective: The objective of our study was to retrospectively compare the diagnostic performance of an AI-based application (PMCardio) with that of interventional cardiologists in interpreting nonpathognomonic ECGs that generated debates about diagnosis. Methods: In total, 33 ECGs that were diagnostically challenging upon patient admission to the emergency department were included. A group of 3 interventional cardiologists, blinded to the final diagnosis, independently assessed whether the ECG suggested OMI requiring immediate invasive coronary angiography. The diagnostic performance of the cardiologists was compared to that of the AI application, using the results of coronary angiography as the gold standard and considering any lesion with ≥90% stenosis as positive. Results: Of the 33 patients, 29 (88%) had a final diagnosis of cardiac origin for their chest pain, including 23 acute coronary syndromes, of which 13 (57%) were OMI. The 3 cardiologists achieved sensitivities of 62%, 85%, and 62%; negative predictive values (NPVs) of 74%, 83%, and 69%; specificities of 70%, 50%, and 55%; and positive predictive values (PPVs) of 57%, 52%, and 47%. Their overall misclassification rates were 33%, 36%, and 42%. In contrast, AI analysis demonstrated a sensitivity and NPV of 100%, a specificity of 60%, a PPV of 62%, and an overall misclassification rate of 24%. Conclusions: In this retrospective study of challenging ECGs, an AI application demonstrated better diagnostic performance of OMI as compared to cardiologists. These findings highlight the potential of AI to enhance diagnostic accuracy and support clinical decision-making.
- 14 October 2026
- Published by JMIR Publications Inc. in JMIR Cardio
- Vol. 10, e88399
Open AccessHuman vs Artificial Intelligence in Detecting Coronary Occlusions in ST-Elevation Myocardial Infarction: Retrospective Study
Background: Occlusion myocardial infarction (OMI) on the electrocardiogram (ECG) can present as ST-elevation myocardial infarction (STEMI), non-STEMI, ST depression, or other patterns (eg, de Winter T waves and hyperacute T waves), posing a diagnostic challenge. Even experienced physicians may overlook OMI on ECG, leading to delays in catheterization laboratory activation. Recently, smartphone apps using AI have been shown to exhibit promising accuracy in ECG interpretation in large datasets. Objective: The objective of our study was to retrospectively compare the diagnostic performance of an AI-based application (PMCardio) with that of interventional cardiologists in interpreting nonpathognomonic ECGs that generated debates about diagnosis. Methods: In total, 33 ECGs that were diagnostically challenging upon patient admission to the emergency department were included. A group of 3 interventional cardiologists, blinded to the final diagnosis, independently assessed whether the ECG suggested OMI requiring immediate invasive coronary angiography. The diagnostic performance of the cardiologists was compared to that of the AI application, using the results of coronary angiography as the gold standard and considering any lesion with ≥90% stenosis as positive. Results: Of the 33 patients, 29 (88%) had a final diagnosis of cardiac origin for their chest pain, including 23 acute coronary syndromes, of which 13 (57%) were OMI. The 3 cardiologists achieved sensitivities of 62%, 85%, and 62%; negative predictive values (NPVs) of 74%, 83%, and 69%; specificities of 70%, 50%, and 55%; and positive predictive values (PPVs) of 57%, 52%, and 47%. Their overall misclassification rates were 33%, 36%, and 42%. In contrast, AI analysis demonstrated a sensitivity and NPV of 100%, a specificity of 60%, a PPV of 62%, and an overall misclassification rate of 24%. Conclusions: In this retrospective study of challenging ECGs, an AI application demonstrated better diagnostic performance of OMI as compared to cardiologists. These findings highlight the potential of AI to enhance diagnostic accuracy and support clinical decision-making.
- 17 August 2026
- Published by Taylor & Francis in Acta Cardiologica
- p. 1-2
Bioresorbable scaffolds after absorb: a magnesium redemption or another false dawn?
Percutaneous coronary intervention (PCI) has revolutionised the treatment of coronary artery disease, which remains one of the leading causes of morbidity and mortality worldwide [1].The introducti...
- 17 August 2026
- Published by Taylor & Francis in Acta Cardiologica
- p. 1-2
Bioresorbable scaffolds after absorb: a magnesium redemption or another false dawn?
Percutaneous coronary intervention (PCI) has revolutionised the treatment of coronary artery disease, which remains one of the leading causes of morbidity and mortality worldwide [1].The introducti...
- Open Access
- 1 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3465
Vessel-Specific Differences in Fractional Flow Reserve Among Intermediate Coronary Lesions
Background/Objectives: Fractional flow reserve (FFR) is the reference standard for assessing the functional significance of intermediate coronary stenoses and guiding revascularization. Although a universal ischemic threshold is applied to all epicardial vessels, potential physiological differences between coronary territories remain insufficiently explored. The aim of this study was to evaluate whether the functional significance of intermediate coronary stenoses differs according to coronary artery and to assess the clinical outcomes of FFR-guided deferral across coronary territories. Methods: This single-center retrospective study included patients who underwent single-vessel FFR assessment for angiographically intermediate lesions between 2019 and 2022. Patients with left main disease or multivessel physiological assessment were excluded. Clinical characteristics, FFR values, and long-term outcomes were analyzed according to the investigated coronary artery. Major adverse cardiovascular events (MACE) were defined as a composite of death, myocardial infarction, and urgent revascularization. Results: A total of 310 patients (corresponding to 310 coronary arteries) were included: 211 LAD, 68 RCA, and 31 LCX lesions. Overall, 18.7% of lesions had a positive FFR (≤0.80). The only variable identified in univariable analysis as being associated with FFR positivity was the coronary artery evaluated (p < 0.001). Positive FFR values were observed in 24.6% of LAD lesions, compared with 8.8% in the RCA and none in the LCX. Among patients with negative FFR for whom revascularization was deferred, five-year MACE-free survival was similar across coronary territories (p = 0.12). Conclusions: The functional significance of intermediate coronary stenoses varies according to the coronary territory, with LAD lesions more frequently reaching ischemic thresholds. However, deferral of revascularization based on negative FFR is associated with favorable long-term outcomes across all vessels, supporting a vessel-specific physiological interpretation of coronary stenoses.
- 1 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (9) , 3465
Open AccessVessel-Specific Differences in Fractional Flow Reserve Among Intermediate Coronary Lesions
Background/Objectives: Fractional flow reserve (FFR) is the reference standard for assessing the functional significance of intermediate coronary stenoses and guiding revascularization. Although a universal ischemic threshold is applied to all epicardial vessels, potential physiological differences between coronary territories remain insufficiently explored. The aim of this study was to evaluate whether the functional significance of intermediate coronary stenoses differs according to coronary artery and to assess the clinical outcomes of FFR-guided deferral across coronary territories. Methods: This single-center retrospective study included patients who underwent single-vessel FFR assessment for angiographically intermediate lesions between 2019 and 2022. Patients with left main disease or multivessel physiological assessment were excluded. Clinical characteristics, FFR values, and long-term outcomes were analyzed according to the investigated coronary artery. Major adverse cardiovascular events (MACE) were defined as a composite of death, myocardial infarction, and urgent revascularization. Results: A total of 310 patients (corresponding to 310 coronary arteries) were included: 211 LAD, 68 RCA, and 31 LCX lesions. Overall, 18.7% of lesions had a positive FFR (≤0.80). The only variable identified in univariable analysis as being associated with FFR positivity was the coronary artery evaluated (p < 0.001). Positive FFR values were observed in 24.6% of LAD lesions, compared with 8.8% in the RCA and none in the LCX. Among patients with negative FFR for whom revascularization was deferred, five-year MACE-free survival was similar across coronary territories (p = 0.12). Conclusions: The functional significance of intermediate coronary stenoses varies according to the coronary territory, with LAD lesions more frequently reaching ischemic thresholds. However, deferral of revascularization based on negative FFR is associated with favorable long-term outcomes across all vessels, supporting a vessel-specific physiological interpretation of coronary stenoses.
- Open Access
- 15 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2691
Aortic Stenosis: Time for a Sex-Based Approach?
Aortic stenosis (AS) is a progressive form of valvular heart disease most commonly associated with aging, with an exponential increase in prevalence after age 50. While men have historically been considered at higher risk, recent studies highlight a similar prevalence between men and women, with a higher prevalence in elderly women driven by longer life expectancy. Sex-related differences in clinical presentation, anatomy, and pathophysiology influence disease progression, severity assessment, and management. Women are often diagnosed at more advanced stages, exhibiting more pronounced symptoms, typically dyspnea and functional impairment, whereas men more often report chest pain. Women have a smaller body surface area, leading to smaller aortic annuli, left ventricular outflow tracts, aortic roots impacting flow dynamic, and severity grading. Diagnostic challenge contributes to the undertreatment of women. Despite experiencing severe AS, women receive fewer interventions and face delays in treatment. The advent of transcatheter aortic valve implantation (TAVI) improved outcomes, with studies suggesting a potential advantage in women compared to men. However, the anatomical differences, such as smaller annuli and more tortuous vascular access, necessitate tailored procedural approaches. Recognizing these sex-specific differences is essential to optimizing AS management, ensuring timely interventions, and improving patient outcomes. Future strategies should incorporate sex-specific thresholds for diagnosis and treatment while leveraging technological advancements, such as artificial intelligence, for personalized therapeutic decisions.
- 15 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2691
Open AccessAortic Stenosis: Time for a Sex-Based Approach?
Aortic stenosis (AS) is a progressive form of valvular heart disease most commonly associated with aging, with an exponential increase in prevalence after age 50. While men have historically been considered at higher risk, recent studies highlight a similar prevalence between men and women, with a higher prevalence in elderly women driven by longer life expectancy. Sex-related differences in clinical presentation, anatomy, and pathophysiology influence disease progression, severity assessment, and management. Women are often diagnosed at more advanced stages, exhibiting more pronounced symptoms, typically dyspnea and functional impairment, whereas men more often report chest pain. Women have a smaller body surface area, leading to smaller aortic annuli, left ventricular outflow tracts, aortic roots impacting flow dynamic, and severity grading. Diagnostic challenge contributes to the undertreatment of women. Despite experiencing severe AS, women receive fewer interventions and face delays in treatment. The advent of transcatheter aortic valve implantation (TAVI) improved outcomes, with studies suggesting a potential advantage in women compared to men. However, the anatomical differences, such as smaller annuli and more tortuous vascular access, necessitate tailored procedural approaches. Recognizing these sex-specific differences is essential to optimizing AS management, ensuring timely interventions, and improving patient outcomes. Future strategies should incorporate sex-specific thresholds for diagnosis and treatment while leveraging technological advancements, such as artificial intelligence, for personalized therapeutic decisions.